Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the distribution and sales for Quviviq (daridorexant 25 and 50mg) in Japan. 1 October 2024
Privately-held German pain specialist Grünenthal has appointed Jan Adams its new chief commercial officer (CCO) and a member of the corporate executive board. 30 September 2024
Acadia Pharmaceuticals has appointed Catherine Owen Adams to succeed Steve Davis as chief executive (CEO) and a member of its board of directors. 28 September 2024
Structure Therapeutics, a specialist in small molecule treatments for metabolic and pulmonary diseases, has announced key leadership appointments. 18 September 2024
Under pressure from certain shareholders, autoimmune diseases specialist Aurinia Pharmaceuticals on Friday said it has restructured its board of directors. 14 September 2024
California’s Lykos Therapeutics is still trying to regroup after being rocked by the US Food and Drug Administration’s (FDA) rejection of midomafetamine (MDMA) capsules for the treatment of post-traumatic stress disorder (PTSD). 6 September 2024
Novocure (Nasdaq: NVCR) has announced that chief executive Asaf Danziger will retire at the end of 2024, with current chief financial officer Ashley Cordova set to succeed him as CEO. 4 September 2024
Lykos Therapeutics has announced a reorganization to best support the company as it works to address the resubmission of its new drug application (NDA) for midomafetamine capsules for the treatment of post-traumatic stress disorder (PTSD) in adults. 16 August 2024
German infectious disease specialist AiCuris Anti-infective Cures has announced the appointment of Cynthia Wat as chief medical officer (CMO). 30 July 2024
Ophirex, a registered public benefit corporation developing an oral field treatment to address the global unmet medical needs of snakebite victims, has announced the appointment of Jeremy Gowler as chief executive. 15 July 2024
US drugmaker AbbVie has announced that Roopal Thakkar, who currently serves as senior vice president, chief medical officer, global therapeutics, has been appointed to the position of executive vice president, research and development, and chief scientific officer (CSO). 10 July 2024
Catherine Owen, senior vice president of major markets at Bristol Myers Squibb, provides an Expert View on why increasing female representation on corporate boards isn’t just a numbers game. Women bring diverse perspectives that are needed more than ever. 7 May 2021
GlaxoSmithKline, the majority shareholder of Galvani Bioelectronic, today announced the termination of Moncef Slaoui as chairman of the Galvani board of directors, effective immediately. 24 March 2021
British clinical stage drug development company Evgen Pharma today announced that Helen Kuhlman will be joining the company as chief business officer, effective April 1, 2021. 22 March 2021
US pharma giant Merck & Co yesterday revealed that Michael Nally, chief marketing officer, Human Health, will leave the company at the end of March, in order to take up a leadership opportunity with another company. 18 March 2021
Eli Lilly saw its shares drop as much as 2.5% yesterday, after it was revealed that its chief financial officer, Josh Smiley, was leaving the company because of ‘inappropriate’ conduct. 10 February 2021
Spanish skincare specialist Almirall has appointed Gianfranco Nazzi as chief executive and executive director of the board of directors effective May 1, 2021. 8 February 2021
German pharma, science and technology company Merck KGAA today announced that Rehan Verjee has made the decision to leave his position as president of its EMD Serono unit and global head of innovative medicine franchises, to pursue an opportunity outside of Merck that will soon be announced. 4 February 2021
Kenneth Frazier, one of the biggest names in pharma, is to retire from his position of chief executive of Merck & Co (NYSE: MRK) after a decade in the role. 4 February 2021
Privately-held Danish medical dermatology specialist LEO Pharma today announced that Jörg Möller will join its global leadership team as executive vice president, global research and development, effective January 1, 2021. 16 December 2020
Novo Seeds, the early-stage investment and company creation team of Novo Holdings, has invested in a new portfolio company Hemab ApS, which is focused on the development of bispecific antibodies for the treatment of rare bleeding disorders. 14 December 2020
The new head of the European Medicines Agency, Emer Cooke, has formally started work in the role, kicking off a five-year renewable mandate as executive director. 16 November 2020
Boehringer Ingelheim said today it has recently welcomed Yew Looi Liew (YL) as the newly-appointed president of US Human Pharma at its US headquarters, Boehringer Ingelheim Pharmaceuticals based in Ridgefield, CT, which is the German family-owned drug major’s largest US subsidiary. 30 October 2020
EXUMA Biotech Corporation, the company discovering and developing CAR-T products and delivery solutions for liquid and solid tumors, has announced an update to its senior leadership team. 19 October 2020